Ketorolac Tromethamine + DexamethasoneThird Party Manufacturing in India

Ketorolac Tromethamine + Dexamethasone works by targeting parallel pathways of the inflammatory cascade within ocular tissues. It inhibits cyclooxygenase enzymes to block pain-inducing prostaglandins and acts on intracellular glucocorticoid receptors to suppress leukotrienes and cellular exudation. Unlike single-mechanism drops, this combination manages both intense postoperative pain and complex immune-mediated tissue swelling. It is highly effective and well-tolerated when used as directed following ocular surgery.

Therapeutic Uses

• Post-Surgical Inflammation: Comprehensive management of severe pain and inflammatory cellular responses following cataract extraction.
• Cystoid Macular Edema Prevention: Mitigation of risk factors associated with retinal macular swelling after complex intraocular procedures.

Why Manufacturers Choose Ketorolac Tromethamine + Dexamethasone

Ketorolac Tromethamine + Dexamethasone third party manufacturing in India provides a valuable combination product for ophthalmic surgeons focused on rapid patient recovery. Our partner facilities maintain absolute sterility using advanced aseptic fill lines that strictly meet WHO-GMP guidelines. This emphasis on WHO-GMP certified design prevents product degradation and ensures chemical stability within the container. Offering this dual-action therapeutic drop addresses an important clinical market, ensuring regular re-orders from distribution networks.